$64.290
-0.887 (-1.38%)At close
DBD Revenue Streams
Diebold Nixdorf Inc (DBD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Services, accounting for 59.3% of total sales, equivalent to $552.40M. Another important revenue stream is Products. Understanding this composition is critical for investors evaluating how DBD navigates market cycles within the Integrated Hardware & Software industry.
DBD Profitability and Margins
Evaluating the bottom line, Diebold Nixdorf Inc maintains a gross margin of 26.29%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.21%, while the net margin is 1.74%. These profitability ratios, combined with a Return on Equity (ROE) of 10.76%, provide a clear picture of how effectively DBD converts its operational activities into shareholder value.
DBD Comparative Benchmarking
In the context of the broader market, DBD competes directly with industry leaders such as FCEL and UMAC. With a market capitalization of $2.16B, it holds a leading position in the sector. When comparing efficiency, DBD's gross margin of 26.29% stands against FCEL's -74.25% and UMAC's 34.25%. Such benchmarking helps identify whether Diebold Nixdorf Inc is trading at a premium or discount relative to its financial performance.
Diebold Nixdorf Inc Financial Performance
Diebold Nixdorf has shown a positive trend in earnings, with Q2 2026 earnings of $15.5 million, or $0.44 per share, up from $12.2 million or $0.33 per share a year earlier. The company also provided full-year EPS guidance of $5.25 to $5.75, reflecting confidence in future performance.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.